Purine nucleoside phosphorylase deficiency: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Template)
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
{{Infobox_Disease |
{{Infobox_Disease |
   Name          = Purine nucleoside phosphorylase deficiency |
   Name          = Purine nucleoside phosphorylase deficiency |
Line 9: Line 10:
   OMIM          = 164050 |
   OMIM          = 164050 |
   MedlinePlus    = |
   MedlinePlus    = |
  eMedicineSubj  = ped |
  eMedicineTopic = 1957 |
   MeshID        = |
   MeshID        = |
}}
}}
{{SI}}
{{SI}}
{{EH}}
{{CMG}}


__NOTOC__
{{SK}} PNP-deficiency
==Overview==
'''Purine nucleoside phosphorylase deficiency''', often called '''PNP-deficiency''', is a rare congenital [[immunodeficiency]] of [[purine nucleoside phosphorylase]]. This enzyme is important in the purine degradation pathway. A deficiency of it causes [[T-cell]] immunodeficiency. It is also often associated with neurological disorders such as [[mental retardation]]. This [[autosomal recessive]] [[metabolic disorder]] results in [[severe combined immunodeficiency]].


==Overview==
==Historical Perspective==


'''Purine nucleoside phosphorylase deficiency''', often called '''PNP-deficiency''', is a rare congenital [[immunodeficiency]] of [[purine nucleoside phosphorylase]]. This enzyme is important in the purine degradation pathway. A deficiency of it causes [[T-cell]] immunodeficiency. It is also often associated with neurological disorders such as [[mental retardation]]. This [[autosomal recessive]] [[metabolic disorder]] results in [[severe combined immunodeficiency]].
==Classification==


==Pathophysiology==
==Pathophysiology==
Line 30: Line 30:
In contrast to [[adenosine deaminase deficiency]] (another deficiency of [[purine metabolism]]), there is minimal disruption to [[B cell]]s.<ref name="urleMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen">{{cite web |url=http://www.emedicine.com/ped/TOPIC1957.HTM |title=eMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen |format= |work= |accessdate=}}</ref>
In contrast to [[adenosine deaminase deficiency]] (another deficiency of [[purine metabolism]]), there is minimal disruption to [[B cell]]s.<ref name="urleMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen">{{cite web |url=http://www.emedicine.com/ped/TOPIC1957.HTM |title=eMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen |format= |work= |accessdate=}}</ref>


==Symptoms==
==Causes==
 
==Differentiating {{PAGENAME}} from Other Diseases==
 
==Epidemiology and Demographics==
===Prevalence===
 
[[Image:autorecessive.svg|thumb|right|Purine nucleoside phosphorylase deficiency has an autosomal recessive pattern of inheritance.]]
PNP-deficiency is extremely rare. Only 33 patients with the disorder in the [[United States]] have been documented.<ref name="pnpone"/> In the United Kingdom only one child has been diagnosed with this disorder.
 
==Risk Factors==
 
==Screening==
 
==Natural History, Complications, and Prognosis==
===Natural History===
 
===Complications===
 
===Prognosis===
 
==Diagnosis==
===Diagnostic Criteria===
 
===History and Symptoms===
In addition to the symptoms associated with immunodeficiency, such as depletion of T-cells, decline of [[lymphocyte]] activity, and an abrupt proliferation of both benign and opportunistic infections, PNP-deficiency is often characterized by the development of [[autoimmune disorder]]s. [[lupus erythematosus|Lupus]]-erythematosis, autoimmune [[hemolytic anemia]], and [[idiopathic thrombocytopenic purpura]] have been reported with PNP-deficiency.<ref name="pnpone">{{cite journal |author=Markert ML |title=Purine nucleoside phosphorylase deficiency |journal=Immunodefic Rev. |volume=3 |issue=1 |pages=45–81 |year=1991 |pmid=1931007 }}</ref>
In addition to the symptoms associated with immunodeficiency, such as depletion of T-cells, decline of [[lymphocyte]] activity, and an abrupt proliferation of both benign and opportunistic infections, PNP-deficiency is often characterized by the development of [[autoimmune disorder]]s. [[lupus erythematosus|Lupus]]-erythematosis, autoimmune [[hemolytic anemia]], and [[idiopathic thrombocytopenic purpura]] have been reported with PNP-deficiency.<ref name="pnpone">{{cite journal |author=Markert ML |title=Purine nucleoside phosphorylase deficiency |journal=Immunodefic Rev. |volume=3 |issue=1 |pages=45–81 |year=1991 |pmid=1931007 }}</ref>


Neurological symptoms, such as developmental decline, [[hypotonia]], and [[mental retardation]] have also been reported.
Neurological symptoms, such as developmental decline, [[hypotonia]], and [[mental retardation]] have also been reported.


==Genetic prevalence==
===Physical Examination===
 
===Laboratory Findings===
 
===Imaging Findings===
 
===Other Diagnostic Studies===
 
==Treatment==
===Medical Therapy===


[[Image:autorecessive.svg|thumb|right|Purine nucleoside phosphorylase deficiency has an autosomal recessive pattern of inheritance.]]
===Surgery===


PNP-deficiency is extremely rare. Only 33 patients with the disorder in the [[United States]] have been documented.<ref name="pnpone"/> In the United Kingdom only one child has been diagnosed with this disorder. <ref>http://www.channel4.com/news/articles/society/health/boy+first+in+uk+with+rare+condition/3022087</ref>
===Prevention===


==References==
==References==
{{reflist}}
{{reflist|2}}


{{SIB}}
{{Immune disorders}}
{{Immune disorders}}
{{Purine, pyrimidine, porphyrin, bilirubin metabolic pathology}}
{{Purine, pyrimidine, porphyrin, bilirubin metabolic pathology}}


 
[[Category:Hematology]]
[[Category:Noninfectious immunodeficiency-related cutaneous conditions]]
[[Category:Immunology]]
[[Category:Genetic disorders]]
[[Category:Autosomal recessive disorders]]
[[Category:Rare diseases]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Neurology]]
[[Category:Neurology]]

Latest revision as of 21:05, 23 June 2016

Purine nucleoside phosphorylase deficiency
ICD-10 D81.5
ICD-9 277.2
OMIM 164050
DiseasesDB 11044

WikiDoc Resources for Purine nucleoside phosphorylase deficiency

Articles

Most recent articles on Purine nucleoside phosphorylase deficiency

Most cited articles on Purine nucleoside phosphorylase deficiency

Review articles on Purine nucleoside phosphorylase deficiency

Articles on Purine nucleoside phosphorylase deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Purine nucleoside phosphorylase deficiency

Images of Purine nucleoside phosphorylase deficiency

Photos of Purine nucleoside phosphorylase deficiency

Podcasts & MP3s on Purine nucleoside phosphorylase deficiency

Videos on Purine nucleoside phosphorylase deficiency

Evidence Based Medicine

Cochrane Collaboration on Purine nucleoside phosphorylase deficiency

Bandolier on Purine nucleoside phosphorylase deficiency

TRIP on Purine nucleoside phosphorylase deficiency

Clinical Trials

Ongoing Trials on Purine nucleoside phosphorylase deficiency at Clinical Trials.gov

Trial results on Purine nucleoside phosphorylase deficiency

Clinical Trials on Purine nucleoside phosphorylase deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Purine nucleoside phosphorylase deficiency

NICE Guidance on Purine nucleoside phosphorylase deficiency

NHS PRODIGY Guidance

FDA on Purine nucleoside phosphorylase deficiency

CDC on Purine nucleoside phosphorylase deficiency

Books

Books on Purine nucleoside phosphorylase deficiency

News

Purine nucleoside phosphorylase deficiency in the news

Be alerted to news on Purine nucleoside phosphorylase deficiency

News trends on Purine nucleoside phosphorylase deficiency

Commentary

Blogs on Purine nucleoside phosphorylase deficiency

Definitions

Definitions of Purine nucleoside phosphorylase deficiency

Patient Resources / Community

Patient resources on Purine nucleoside phosphorylase deficiency

Discussion groups on Purine nucleoside phosphorylase deficiency

Patient Handouts on Purine nucleoside phosphorylase deficiency

Directions to Hospitals Treating Purine nucleoside phosphorylase deficiency

Risk calculators and risk factors for Purine nucleoside phosphorylase deficiency

Healthcare Provider Resources

Symptoms of Purine nucleoside phosphorylase deficiency

Causes & Risk Factors for Purine nucleoside phosphorylase deficiency

Diagnostic studies for Purine nucleoside phosphorylase deficiency

Treatment of Purine nucleoside phosphorylase deficiency

Continuing Medical Education (CME)

CME Programs on Purine nucleoside phosphorylase deficiency

International

Purine nucleoside phosphorylase deficiency en Espanol

Purine nucleoside phosphorylase deficiency en Francais

Business

Purine nucleoside phosphorylase deficiency in the Marketplace

Patents on Purine nucleoside phosphorylase deficiency

Experimental / Informatics

List of terms related to Purine nucleoside phosphorylase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: PNP-deficiency

Overview

Purine nucleoside phosphorylase deficiency, often called PNP-deficiency, is a rare congenital immunodeficiency of purine nucleoside phosphorylase. This enzyme is important in the purine degradation pathway. A deficiency of it causes T-cell immunodeficiency. It is also often associated with neurological disorders such as mental retardation. This autosomal recessive metabolic disorder results in severe combined immunodeficiency.

Historical Perspective

Classification

Pathophysiology

The disorder is caused by a disruption of the purine nucleoside phosphorylase, a key enzyme in the purine salvage pathway.

This enzyme is required for purine degradation. Specifically, it catalyzes the conversion of inosine and guanosine to hypoxanthine. A deficiency of it leads to build up of elevated deoxy-GTP (dGTP) levels resulting in T-cell toxicity and deficiency.[1][2]

In contrast to adenosine deaminase deficiency (another deficiency of purine metabolism), there is minimal disruption to B cells.[3]

Causes

Differentiating Purine nucleoside phosphorylase deficiency from Other Diseases

Epidemiology and Demographics

Prevalence

File:Autorecessive.svg PNP-deficiency is extremely rare. Only 33 patients with the disorder in the United States have been documented.[4] In the United Kingdom only one child has been diagnosed with this disorder.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

In addition to the symptoms associated with immunodeficiency, such as depletion of T-cells, decline of lymphocyte activity, and an abrupt proliferation of both benign and opportunistic infections, PNP-deficiency is often characterized by the development of autoimmune disorders. Lupus-erythematosis, autoimmune hemolytic anemia, and idiopathic thrombocytopenic purpura have been reported with PNP-deficiency.[4]

Neurological symptoms, such as developmental decline, hypotonia, and mental retardation have also been reported.

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

  1. Snyder FF, Jenuth JP, Mably ER, Mangat RK (1997). "Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse". Proc. Natl. Acad. Sci. U.S.A. 94 (6): 2522–7. doi:10.1073/pnas.94.6.2522. PMC 20121. PMID 9122228. Unknown parameter |month= ignored (help)
  2. Toro A, Grunebaum E (2006). "TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice". J. Clin. Invest. 116 (10): 2717–26. doi:10.1172/JCI25052. PMC 1560347. PMID 16964310. Unknown parameter |month= ignored (help)
  3. "eMedicine - Purine Nucleoside Phosphorylase Deficiency : Article by Alan P Knutsen".
  4. 4.0 4.1 Markert ML (1991). "Purine nucleoside phosphorylase deficiency". Immunodefic Rev. 3 (1): 45–81. PMID 1931007.

Template:Purine, pyrimidine, porphyrin, bilirubin metabolic pathology


Template:WikiDoc Sources